Vol 6, No 6 (December 2017): Translational Lung Cancer Research (Imaging- and blood-based biomarkers for lung cancer precision medicine)


Feng-Ming (Spring) Kong

Original Article

Ensuring sample quality for blood biomarker studies in clinical trials: a multicenter international study for plasma and serum sample preparation
Feng-Ming (Spring) Kong, Lujun Zhao, Luhua Wang, Yuhchyau Chen, Jie Hu, Xiaolong Fu, Chunxue Bai, Li Wang, Theodore S. Lawrence, Mitchell S. Anscher, Adam Dicker, Paul Okunieff

Review Article

Radiomics in precision medicine for lung cancer
Julie Constanzo, Lise Wei, Huan-Hsin Tseng, Issam El Naqa
Blood-based tumor biomarkers in lung cancer for detection and treatment
Hirva Mamdani, Shahid Ahmed, Samantha Armstrong, Tony Mok, Shadia I. Jalal
Blood-based biomarkers for precision medicine in lung cancer: precision radiation therapy
Dirk De Ruysscher, Jianyue Jin, Tim Lautenschlaeger, Jin-Xiong She, Zhongxing Liao, Feng-Ming (Spring) Kong
Anatomic, functional and molecular imaging in lung cancer precision radiation therapy: treatment response assessment and radiation therapy personalization
Michael MacManus, Sarah Everitt, Tanja Schimek-Jasch, X. Allen Li, Ursula Nestle, Feng-Ming (Spring) Kong
Magnetic resonance imaging in precision radiation therapy for lung cancer
Hannah Bainbridge, Ahmed Salem, Rob H. N. Tijssen, Michael Dubec, Andreas Wetscherek, Corinne Van Es, Jose Belderbos, Corinne Faivre-Finn, Fiona McDonald, on behalf of the lung tumour site group of the international Atlantic MR-Linac Consortium


The focused issue “Imaging- and blood-based biomarkers for lung cancer precision medicine” was commissioned by the editorial office, Translational Lung Cancer Research without any sponsorship or funding. Feng-Ming (Spring) Kong served as the unpaid Guest Editor for the focused issue.